About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 413802, 7 pages
http://dx.doi.org/10.1155/2011/413802
Research Article

Technetium-99m-Labeled Autologous Serum Albumin: A Personal-Exclusive Source of Serum Component

1College of Medicine, Tzu Chi University, Hualien 97004, Taiwan
2Department of Nuclear Medicine, Buddhist Dalin Tzu Chi General Hospital, Chiayi 62247, Taiwan
3Division of Nephrology, Department of Internal Medicine, Buddhist Dalin Tzu Chi General Hospital, Chiayi 62247, Taiwan
4Department of Hematology and Oncology, Buddhist Dalin Tzu Chi General Hospital, Chiayi 62247, Taiwan
5Department of Pharmacy, Buddhist Dalin Tzu Chi General Hospital, Chiayi 62247, Taiwan

Received 31 December 2010; Accepted 3 March 2011

Academic Editor: Lie-Hang Shen

Copyright © 2011 Yuh-Feng Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Vanhove, N. Walgraeve, F. De Geeter, and P. R. Franken, “Gated myocardial perfusion tomography versus gated blood pool tomography for the calculation of left ventricular volumes and ejection fraction,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 29, no. 6, pp. 735–741, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. S. Ferraro, P. Perrone-Filardi, A. Desiderio et al., “Left ventricular systolic and diastolic function in severe obesity: A radionuclide study,” Cardiology, vol. 87, no. 4, pp. 347–353, 1996. View at Scopus
  3. N. T. Chiu, B. F. Lee, S. J. Hwang, J. M. Chang, G. C. Liu, and H. S. Yu, “Protein-losing enteropathy: diagnosis with (99m)Tc-labeled human serum albumin scintigraphy,” Radiology, vol. 219, no. 1, pp. 86–90, 2001. View at Scopus
  4. I. Bedrosian, A. M. Scheff, R. Mick et al., “99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma,” Journal of Nuclear Medicine, vol. 40, no. 7, pp. 1143–1148, 1999. View at Scopus
  5. Y. C. Chen, S. J. Hwang, J. S. Chiu, M. H. Chuang, M. I. Chung, and Y. F. Wang, “Chronic edema from protein-losing enteropathy: scintigraphic diagnosis,” Kidney International, vol. 75, no. 10, p. 1124, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. R. Kim, A. Osaki, J. Kojima, and T. Toge, “Significance of lymphoscintigraphic mapping with Tc-99m human serum albumin and tin colloid in sentinel lymph node biopsy in breast cancer,” International journal of oncology, vol. 19, no. 5, pp. 991–996, 2001. View at Scopus
  7. M. Momose, S. Kawakami, T. Koizumi et al., “Lymphoscintigraphy using technetium-99m HSA-DTPA with SPECT/CT in chylothorax after childbirth,” Radiation Medicine, vol. 26, no. 8, pp. 508–511, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. B. R. Don and G. Kaysen, “Serum albumin: relationship to inflammation and nutrition,” Seminars in Dialysis, vol. 17, no. 6, pp. 432–437, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. L. T. Goodnough, “Risks of blood transfusion,” Critical Care Medicine, vol. 31, no. 12, pp. S678–S686, 2003. View at Scopus
  10. C. Madjdpour, V. Heindl, and D. R. Spahn, “Risks, benefits, alternatives and indications of allogenic blood transfusions,” Minerva Anestesiologica, vol. 72, no. 5, pp. 283–298, 2006. View at Scopus
  11. W. R. Mayr, “The reality of self-sufficiency,” Transfusion Clinique et Biologique, vol. 12, no. 5, pp. 362–364, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. The President’s Emergency Plan for AIDS Relief, “Report on blood safety and HIV/AIDS,” June 2006, http://www.pepfar.gov/progress/76858.htm.
  13. Centers for Disease Control and Prevention (CDC), “Progress toward strengthening blood transfusion services—14 countries, 2003-2007,” Morbidity and Mortality Weekly Report, vol. 57, no. 47, pp. 1273–1277, 2008.
  14. Y. F. Wang, M. H. Chuang, J. S. Chiu, T. M. Cham, and M. I. Chung, “On-site preparation of technetium-99m labeled human serum albumin for clinical application,” Tohoku Journal of Experimental Medicine, vol. 211, no. 4, pp. 379–385, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. L. T. Goodnough, M. E. Brecher, M. H. Kanter, and J. P. Aubuchon, “Transfusion medicine: II. Blood conservation,” New England Journal of Medicine, vol. 340, no. 7, pp. 525–533, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. R. Karger and V. Kretschmer, “Modern concepts of autologous haemotherapy,” Transfusion and Apheresis Science, vol. 32, no. 2, pp. 185–196, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. E. Gianazza and P. Arnaud, “Chromatography of plasma proteins on immobilized Cibacron Blue F3-GA. Mechanism of the molecular interaction,” Biochemical Journal, vol. 203, no. 3, pp. 637–641, 1982. View at Scopus
  18. “Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference values,” The New England Journal of Medicine, vol. 314, no. 1, pp. 39–19, 1986.
  19. U.S. Pharmacopeia, “Bacterial endotoxin test,” in USP32/NF27: United States Pharmacopeia and National Formulary, pp. 93–96, The United States Pharmacopeial Convention Inc., 2009.
  20. U.S. Pharmacopeia, “Sterility test,” in USP32/NF27: United States Pharmacopeia and National Formulary, pp. 80–86, The United States Pharmacopeial Convention Inc., 2009.
  21. P. T. Toy, R. G. Strauss, and L. C. Stehling, “Predeposited autologous blood for elective surgery. A national multicenter study,” New England Journal of Medicine, vol. 316, no. 9, pp. 517–520, 1987. View at Scopus
  22. K. Kristensen, “Biodistribution in rats of 99mTc-labelled human serum albumin,” Nuclear Medicine Communications, vol. 7, no. 8, pp. 617–624, 1986. View at Scopus
  23. A. C. Perkins and M. Frier, “Experimental biodistribution studies of 99mTc-recombinant human serum albumin (rHSA): a new generation of radiopharmaceutical,” European Journal of Nuclear Medicine, vol. 21, no. 11, pp. 1231–1233, 1994. View at Scopus
  24. S. Matsushita, Y. Isima, V. T. Chuang et al., “Functional analysis of recombinant human serum albumin domains for pharmaceutical applications,” Pharmaceutical Research, vol. 21, no. 10, pp. 1924–1932, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Kobayashi, “Summary of recombinant human serum albumin development,” Biologicals, vol. 34, no. 1, pp. 55–59, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. K. Langer, M. G. Anhorn, I. Steinhauser et al., “Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation,” International Journal of Pharmaceutics, vol. 347, no. 1-2, pp. 109–117, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. A. Kasahara, K. Kita, E. Tomita, J. Toyota, Y. Imai, and H. Kumada, “Repeated administration of recombinant human serum albumin caused no serious allergic reactions in patients with liver cirrhosis: a multicenter clinical study,” Journal of Gastroenterology, vol. 43, no. 6, pp. 464–472, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. W. Ohtani, Y. Nawa, K. Takeshima, H. Kamuro, K. Kobayashi, and T. Ohmura, “Physicochemical and immunochemical properties of recombinant human serum albumin from Pichia pastoris,” Analytical Biochemistry, vol. 256, no. 1, pp. 56–62, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus